I. B. R. Duncan

3.5k citations

72 papers · 2.8k indexed · 1 hit paper · h-index 24

Co-authors: Jane Craig Dianne Duncan E. A. Burgess John Mills N. A. Roberts Helmut Jacobsen C. R. Pringle John H. Merrett
Topics: HIV/AIDS drug development and treatment (20 papers)HIV Research and Treatment (16 papers)Antibiotic Resistance in Bacteria (10 papers)
Cited by: Virology Infectious Diseases Molecular Medicine
Journals: Nature Science The Lancet
Partner nations: United Kingdom Canada United States

In The Last Decade

I. B. R. Duncan

64 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Design of Peptide-Based HIV Proteinase Inhibitors

1990 726 citations Joseph A. Martin, Jane Craig et al. profile →

Peers

Countries citing papers authored by I. B. R. Duncan

Since Specialization

Citations

This map shows the geographic impact of I. B. R. Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. B. R. Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. B. R. Duncan more than expected).

Fields of papers citing papers by I. B. R. Duncan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. B. R. Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. B. R. Duncan. The network helps show where I. B. R. Duncan may publish in the future.

Co-authorship network of co-authors of I. B. R. Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of I. B. R. Duncan. A scholar is included among the top collaborators of I. B. R. Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. B. R. Duncan. I. B. R. Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy 1998 ·AIDS ·Charles Craig,Esther Race,(unknown),Lynne Whittaker,(unknown),(unknown),(unknown),(unknown),Gung‐Wei Chirn,I. B. R. Duncan,Nick Cammack	52
2	Correlation of response to treatment and HIV genotypic changes during Phase III trials with saquinavir and reverse transcriptase inhibitor combination therapy 1998 ·AIDS ·Esther Race,(unknown),(unknown),(unknown),(unknown),Gisela Sitbon,(unknown),Nick Cammack,I. B. R. Duncan	26
3	Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4 + lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity 1996 ·Antiviral Research ·Stefano Vella,Clementina Maria Galluzzo,Giacomo Giannini,Maria Franca Pirillo,I. B. R. Duncan,Helmut Jacobsen,Massimo Andreoni,Loredana Sarmati,Lucia Ercoli	20
4	How do single homeotic genes control multiple segment identities? 1996 ·BioEssays ·I. B. R. Duncan	17
5	Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials 1996 ·Antiviral Research ·Helmut Jacobsen,(unknown),Michael Ott,I. B. R. Duncan,Massimo Andreoni,Stefano Vella,Jan Mous	18
6	In Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and Frequencies 1996 ·The Journal of Infectious Diseases ·Helmut Jacobsen,(unknown),Michael Ott,I. B. R. Duncan,S. Owen,Massimo Andreoni,Stefano Vella,Jan Mous	147
7	Characterization of human immunodeficiency virus type 1 mutantswith decreased sensitivity to proteinase inhibitor Ro 31-8959 1995 ·Virology ·Helmut Jacobsen,(unknown),Dean L. Winslow,Jane Craig,(unknown),I. B. R. Duncan,Jan Mous	173
8	Safety and activity of saquinavir in HIV infection 1995 ·The Lancet ·V. S. Kitchen,Charlotte Skinner,Koya Ariyoshi,Jonathan Weber,A J Pinching,Elizabeth A. Lane,I. B. R. Duncan,J Burckhardt,Hans Ulrich Burger,K. Bragman	148
9	Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1) 1990 ·Journal of Medicinal Chemistry ·(unknown),(unknown),I. B. R. Duncan,(unknown),Michael J. Hall,(unknown),John H. Merrett,(unknown),N. A. Roberts	63
10	Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides 1989 ·Journal of Medicinal Chemistry ·Robert Lambert,Joseph A. Martin,(unknown),I. B. R. Duncan,Michael J. Hall,Edgar P. Heimer	29
11	Contributions to Microbiology and Immunology 1978 ·Canadian Medical Association Journal ·I. B. R. Duncan	107
12	CONTROL OF HOSPITAL INFECTION. A Practical Handbook 1976 ·Canadian Medical Association Journal ·I. B. R. Duncan	7
13	Virology in a general hospital. 1968 ·PubMed ·I. B. R. Duncan	2
14	Lincomycin in hospital practice. 1965 ·PubMed Central ·I. B. R. Duncan,(unknown)	17
15	Rapid Laboratory Diagnosis of an Outbreak of Influenza. 1963 ·PubMed ·I. B. R. Duncan,A Watt,(unknown)	2
16	Meningitis in an adult due to listeria monocytogenes. 1962 ·PubMed ·I. B. R. Duncan,(unknown)	3
17	TYPE-3 ADENOVIRUS INFECTION WITH GASTROINTESTINAL SYMPTOMS 1961 ·The Lancet ·I. B. R. Duncan,J. G. P. Hutchison	33
18	ASEPTIC MENINGITIS ASSOCIATED WITH A PREVIOUSLY UNRECOGNISED VIRUS 1960 ·The Lancet ·I. B. R. Duncan	20
19	"NOT POLIOMYELITIS" 1959 ·The Lancet ·N. R. Grist,I. B. R. Duncan,(unknown),J. Stevenson	0
20	GROWTH OF CLOSTRIDIUM WELCHII IN THE STOMACH AFTER PARTIAL GASTRECTOMY 1953 ·The Lancet ·J. W. Howie,I. B. R. Duncan,(unknown)	22

About I. B. R. Duncan

I. B. R. Duncan is a scholar working on Virology, Molecular Medicine and Infectious Diseases, having authored 72 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (16 papers) and Antibiotic Resistance in Bacteria (10 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (1.6k citations) and Molecular Medicine (164 citations). I. B. R. Duncan has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Jane Craig, Dianne Duncan, E. A. Burgess, John Mills, N. A. Roberts, Helmut Jacobsen, C. R. Pringle, John H. Merrett, Jan Mous and Joseph A. Martin. Their work appears in journals such as Nature, Science and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact